ADVENZYMES — Advanced Enzyme Technologies Cashflow Statement
0.000.00%
- IN₹31.58bn
- IN₹27.29bn
- IN₹6.24bn
- 91
- 27
- 34
- 51
Annual cashflow statement for Advanced Enzyme Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1,792 | 2,104 | 1,711 | 1,404 | 1,878 |
Depreciation | |||||
Non-Cash Items | 24.5 | -41.5 | -18.2 | 19.3 | -62.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -665 | -711 | -819 | -370 | -755 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,409 | 1,635 | 1,223 | 1,404 | 1,414 |
Capital Expenditures | -507 | -194 | -281 | -381 | -423 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 61.5 | -65.9 | 243 | -2,601 | -223 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -445 | -260 | -37.9 | -2,982 | -646 |
Financing Cash Flow Items | -24.9 | -15.4 | -229 | -92.2 | -85.3 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -386 | -263 | -485 | -258 | -592 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 596 | 1,093 | 754 | -1,709 | 173 |